| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |